Pyc Therapeutics Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
PYC Therapeutics Limited, a clinical stage drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. It is developing PYC-003, which is in Phase1a/1b multiple ascending dose study for polycystic kidney disease; PYC-002, a Phelan McDermid Syndrome; PYC-001 for the treatment of Phelan-McDermid Syndrome; PYC-001, which is in Phase 1b multiple ascending dose study for autosomal dominant optic atrophy; and VP-001 for the treatment of retinitis pigmentosa type 11. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
Key Metrics
PE ratio
-
PB ratio
3.96
Dividend yield
-
Beta
1.08
Market cap
$2.74B
Enterprise value
$2.18B
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://pyctx.com |
| Mailing address | Harry Perkins Institute of Medical Research 6 Verdun Street Nedlands WA 6009 Australia |
| Phone / Fax | 61 8 6151 0992 / |
Dividends
More: Pyc Therapeutics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Pyc Therapeutics paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PYC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on Pyc Therapeutics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.) | CEO & Executive Director | 42 | |
| Mr. Thomas Ulmer | Chief Financial Officer | 46 | |
| Mr. Garrett Bray | Chief Operating Officer | ||
| Dr. Janya Grainok | Chief Scientific Officer | ||
| Mr. Jonathan Riley | General Counsel & Joint Company Secretary | ||
| Dr. Paula Cunningham | Chief Development Officer | ||
| Mr. Stephen Alan Ledger | Joint Company Secretary |
Profitability and management effectiveness
Profit margin
-166.73%
Operating margin
-188.25%
Return on assets
-8.05%
Return on equity
-10.14%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Pyc Therapeutics is 2.74B and its enterprise value is 2.18B. The enterprise value to revenue ratio of PYC is 83.83. The enterprise value to EBITDA ratio of PYC is -38.51.
The PYC's stocks Beta value is 1.08 making it 8% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Pyc Therapeutics (PYC)
Pyc Therapeutics (ASX:PYC) Frequently Asked Questions
1. What is Pyc Therapeutics's Stock Symbol?
Pyc Therapeutics trades on ASX under the ticker symbol "PYC".
2. What is Pyc Therapeutics's stock price today?
One share of PYC stock can currently be purchased for approximately $2.79.
3. How can I contact Pyc Therapeutics?
Pyc Therapeutics's mailing address is Harry Perkins Institute of Medical Research 6 Verdun Street Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 6151 0992.
4. What is Pyc Therapeutics's official website?
The official website of Pyc Therapeutics is https://pyctx.com.